Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Go back to Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs| Cocrystal Pharma, Inc. (NASDAQ: COCP) | Delayed: 1.05 +0.05 (5.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.00 | 52 Week High | $0.92 | |||
| Open | $1.00 | 52 Week Low | $0.32 | |||
| Day High | $1.06 | P/E | N/A | |||
| Day Low | $1.01 | EPS | $-0.18 | |||
| Volume | 76,515 | |||||
